Skip to main content

Advertisement

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

The original article was published in Molecular Cancer 2014 13:194

Correction

After publication of this work [1], we noted that we repeatedly had a typo mistake across the manuscript. The compound we used to test our cell lines was SCH772984 and not SCH722984. The typo was found misspelled in 54 occasions, including the title.

We also wanted to add an affiliation detail to the author’s list, as noted above.

We regret the mistake and upload this note to clarify it.

Reference

  1. 1.

    Wong DJ, Robert L, Atefi MS, Lassen A, Avarappatt G, Cerniglia M. Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma. Mol Cancer. 2014;13:194. doi:10.1186/1476-4598-13-194.

Download references

Author information

Correspondence to Antoni Ribas.

Additional information

Deborah JL Wong and Lidia Robert contributed equally to this work.

The online version of the original article can be found under doi:10.1186/1476-4598-13-194.

Rights and permissions

Reprints and Permissions

About this article